EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic probability classification in suspected borreliosis by a novel Borrelia C6-peptide IgG1- subclass antibody test

Dag Nyman, Marika Nordberg, Clara Nyberg, Susanne Olausson, Nellie Carlströmer Berthen, Sten-Anders Carlsson

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1108115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Dag Nyman und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Åland Group for Borreliosis Research, Mariehamn, Finland. Hauptthemen laut MEDLINE: Borrelia, Borrelia burgdorferi Group, Lyme Disease, Borrelia burgdorferi. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tick-borne multisystemic infection caused by Borrelia burgdorferi sensu lato , Lyme borreliosis, or Lyme disease, occurring in temperate regions of the northern hemisphere, continues to spread geographically with the expanding tick population. Despite the rising perceived risk of infection in the population, the clinical diagnosis of Borrelia infection is not always obvious and the most important laboratory test, antibody detection, has limited accuracy in diagnosing active disease. According to international guidelines, the primary serology test, which has a high sensitivity-low specificity, should, be verified using a high specificity confirmation test to improve the specificity. However, this enhancement in specificity comes at the cost of lower sensitivity. This two-step procedure is often omitted in everyday clinical practice. An optimal primary test would be one where no secondary tests for confirmation would be necessary. In the present study, the performance of a novel assay for quantitating IgG1-subclass antibodies to Borrelia C6-peptide was compared to a commercial reference assay of total IgG and IgM antibodies to Borrelia C6-peptide in the setting of a high endemic area for borreliosis. A derivation study on a retrospective clinical material was performed to compare the performance parameters and assess the discriminatory properties of the assays, followed by a prospective validation study. The IgG1-antibody assay achieved comparable summary performance parameters to those of the reference assay. The sensitivity was almost 100% while the specificity was about 50%. In a high-endemic setting, characterized by high background seropositivity of about 50% and disease prevalence of approximately 10%, antibody tests are unable to rule-in active Borrelia infection. The rule-out assessment of the methods revealed that of 1000 patients, 7 – 54 with negative results based on the reference method could have an active Borrelia infection. Such uncertainty was not found for the index test and may help improve the risk classification of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BorreliaBorrelia burgdorferi GroupLyme DiseaseBorrelia burgdorferiHumansRetrospective StudiesImmunoglobulin GPeptidesProbabilityAntibodies, Bacterial

Stichwörter der Autor:innen

Borrelia infectionC6-peptideIgG1-antibodydiagnosticsprobabilityserology

Substanzen

Immunoglobulin GPeptidesAntibodies, Bacterial

Autor:innen und Institutionen

  • The Åland Group for Borreliosis Research, Mariehamn, Finland.
  • Bimelix Laboratory, Mariehamn, Finland.
  • Department of Infection, Åland Public Health Care Services, Mariehamn, Finland.

Zitieren

APA

Nyman, D., Nordberg, M., Nyberg, C., Olausson, S., Carlströmer Berthen, N., & Carlsson, S. A. (2023). Diagnostic probability classification in suspected borreliosis by a novel Borrelia C6-peptide IgG1- subclass antibody test. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1108115

Vancouver

Nyman D, Nordberg M, Nyberg C, Olausson S, Carlströmer Berthen N, Carlsson SA. Diagnostic probability classification in suspected borreliosis by a novel Borrelia C6-peptide IgG1- subclass antibody test. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1108115

BibTeX
@article{Nyman2023,
  author = {Nyman, Dag and Nordberg, Marika and Nyberg, Clara and Olausson, Susanne and Carlströmer Berthen, Nellie and Carlsson, Sten-Anders},
  title = {Diagnostic probability classification in suspected borreliosis by a novel Borrelia C6-peptide IgG1- subclass antibody test},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1108115}
}
Kostenlos starten →